Eventide Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History

Eventide Asset Management, LLC

$5.26 Billion
Q2 2025

A detailed history of Eventide Asset Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 2,637,485 shares of MIRM stock, worth $189 Million. This represents 2.55% of its overall portfolio holdings.

Number of Shares

2,637,485

Previous 2,527,000 4.37%

Holding current value

$189 Million

Previous $114 Million 17.9%

% of portfolio

2.55%

Previous 2.42%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$38.39 - $51.11 $4.24 Million - $5.65 Million	110,485 Added 4.37%	2,637,485 $134 Million
Q1 2025 May 15, 2025	SELL	$41.32 - $53.16 $3.3 Million - $4.25 Million	-79,938 Reduced 3.07%	2,527,000 $114 Million
Q4 2024 Feb 14, 2025	SELL	$37.85 - $46.65 $31.7 Million - $39.1 Million	-838,425 Reduced 24.33%	2,606,938 $108 Million
Q3 2024 Nov 14, 2024	SELL	$33.68 - $44.74 $5.71 Million - $7.58 Million	-169,457 Reduced 4.69%	3,445,363 $134 Million
Q2 2024 Aug 13, 2024	BUY	$23.57 - $34.85 $7.41 Million - $11 Million	314,420 Added 9.53%	3,614,820 $124 Million
Q1 2024 May 15, 2024	BUY	$24.92 - $30.02 $15.9 Million - $19.1 Million	636,751 Added 23.91%	3,300,400 $82.9 Million
Q4 2023 Feb 20, 2024	SELL	$27.14 - $34.93 $25.8 Million - $33.2 Million	-950,000 Reduced 26.29%	2,663,649 $78.6 Million
Q4 2023 Feb 14, 2024	SELL	$27.14 - $34.93 $9.36 Million - $12 Million	-344,930 Reduced 8.71%	3,613,649 $107 Million
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $12.3 Million - $16.4 Million	499,378 Added 14.44%	3,958,579 $125 Million
Q2 2023 Aug 15, 2023	BUY	$23.51 - $30.09 $32.9 Million - $42.1 Million	1,400,000 Added 67.99%	3,459,201 $89.5 Million
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $42,237 - $53,044	2,201 Added 0.11%	2,059,201 $49.5 Million
Q4 2022 Feb 13, 2023	BUY	$17.59 - $23.83 $13.8 Million - $18.6 Million	782,000 Added 61.33%	2,057,000 $40.1 Million
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $25.5 Million - $37.5 Million	1,275,000 New	1,275,000 $26.8 Million

Others Institutions Holding MIRM

# of Institutions

230

Shares Held

56.1M

Call Options Held

25.3K

Put Options Held

98.9K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $2.64B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Account

Eventide Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History